Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AstraZeneca pauses two cancer drug trials' enrolment due to bleeding
Friday, October 28, 2016AstraZenecas high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold following instances of bleeding The drugmaker said the US Food and Drug A...
Aerie Pharma reports positive topline results of late stage study of Rhopressatm
Friday, October 28, 2016Aerie Pharmaceuticals reports positive topline efficacy results of ROCKET phase trial of Rhopressatm netarsudil ophthalmic solution percent Aerie Pharmaceuticals Inc Study successfully achieves primary efficacy endpoint Aerie Pharmaceuticals In...
China Resources Pharma Falls in Hong Kong After $1.8 Billion IPO
Friday, October 28, 2016China Resources Pharmaceutical Group Ltd fell in its Hong Kong trading debut after raising about billion in the largest initial public offering globally from a drugmaker since The stock traded percent lower at HK at am in Hong Kong The Beijingba...
Astellas to Acquire Ganymed Pharmaceuticals
Friday, October 28, 2016Astellas Pharma Inc and Ganymed Pharmaceuticals AG a biopharmaceutical company located in Mainz Germany which focuses on the development of antibodies against cancer announced today that Astellas and Ganymeds shareholders have entered into an agreeme...
Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.
Thursday, October 27, 2016Horizon Pharma plc HZNP a biopharmaceutical company focused on improving patients lives by identifying developing acquiring and commercializing differentiated and accessible medicines that address unmet medical needs today announced that it has compl...
Minerva Neurosciences posts positive data on schizophrenia drug
Thursday, October 27, 2016Minerva neurosciences announces positive data from sixmonth extension of phase iib trial of min monotherapy in schizophrenia Minerva neurosciences min was reported to be well tolerated at both doses over entire week duration of study by schizophreni...
EpiPen rival plans return to U.S. market in first-half 2017
Thursday, October 27, 2016Privately held drugmaker Kaleo Inc announced on Wednesday plans for a US relaunch of its AuviQ injector for lifethreatening allergic reactions in the first half of next year AuviQ designed to deliver the same epinephrine drug as Mylan NVs EpiPen was...
Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma
Thursday, October 27, 2016Auven Therapeutics an international private equity company focused on accelerated development of breakthrough therapeutic drugs today announced the execution of definitive agreements for the sale of percent of Ocular Technologies Sarl a wholly owned...
Serodus: Orphan Drug Designation for SER100 in PAH
Wednesday, October 26, 2016Serodus ASA Said on Tuesday Office of Orphan Products Development United States Food and Drug Administration FDA has granted Orphan Drug Designation for SER in pulmonary arterial hypertension PAH Subject to financing Serodus will plan for first clin...
Novartis CEO sees tougher U.S. drug pricing over next three-five years
Wednesday, October 26, 2016Novartis expects a more difficult pricing environment for drugs in the United States in the years ahead its chief executive told a results conference call on Tuesday We expect pricing to become more difficult in the US over the next three to five ye...
